Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-22

Clinical Trial Update: IV Lacosamide: The Safety of Intravenous Lacosamide [Phase 3]

View source ↗

Summary

Phase 3 study assessing the safety of intravenous lacosamide in epilepsy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide IV (lacosamide)

Snippet

Sponsor: Le Bonheur Children's Hospital | Conditions: Epilepsy | Phase 3 | Status: COMPLETED